Skip to main content
KMPHARMACEUTICAL Co.,Ltd. logo

KMPHARMACEUTICAL Co.,Ltd. — Investor Relations & Filings

Ticker · 225430 ISIN · KR7225430008 KO Manufacturing
Open in API
Filings indexed 233 across all filing types
Latest filing 2020-09-10 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 225430

About KMPHARMACEUTICAL Co.,Ltd.

https://en.kmkmp.com/

KMPHARMACEUTICAL Co., Ltd. is a company that develops, manufactures, and distributes personal care products. Its core business areas include oral care solutions, such as toothpaste and toothbrushes; beauty and skincare products; and a dedicated line of items for infants and children. The company leverages its research and development expertise to provide Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, creating customized products tailored to client needs in the oral care and cosmetics sectors. It focuses on developing innovative solutions and adheres to strict quality standards, particularly for its children's product lines.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a decision for a paid-in capital increase (유상증자결정) by KM Pharmaceutical Co., Ltd. It details the issuance of new shares, the purpose of the funds, the allocation method, and the subscription schedule. This falls under the category of announcements regarding new share issues or capital changes.
2020-09-10 Korean
증권신고서(지분증권)
Capital/Financing Update Classification · 100% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission (FSC) in South Korea. It details a capital increase (유상증자) through a rights offering followed by a public offering of unsubscribed shares (주주배정후 실권주 일반공모). This document is a formal regulatory filing required for public capital raising activities. Among the provided categories, 'CAP' (Capital/Financing Update) is the most accurate classification for a Securities Registration Statement detailing a capital raise.
2020-09-10 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for KM Pharmaceutical Co., Ltd. covering the period from January 1, 2020, to June 30, 2020. It contains detailed corporate information, history, capital changes, and governance details, which are characteristic of a comprehensive interim financial report. It is not an announcement of a report (RPA) or a simple regulatory filing (RNS), as it provides substantive financial and operational data for the specified period. H1 2020
2020-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of a major shareholder (Kang Il-mo) in KM Pharmaceutical Co., Ltd. This type of filing is a mandatory disclosure for significant shareholders and falls under the category of Major Shareholding Notification.
2020-07-15 Korean
조회공시요구(현저한시황변동)에대한답변(중요정보없음)
Regulatory Filings Classification · 95% confidence The document is a formal response to a Korea Exchange (KRX) inquiry regarding significant market fluctuations (unusual stock price/volume activity). It explicitly states that there is no material non-public information to disclose. This type of regulatory response to a market inquiry is a standard regulatory filing that does not fit into specific categories like earnings or dividends, thus falling under the general regulatory filing category.
2020-05-29 Korean
조회공시요구(현저한시황변동)
Regulatory Filings Classification · 95% confidence The document is a formal request from a regulatory body (exchange) to the company (KM Pharmaceutical) regarding significant market fluctuations in its stock price. It is a standard regulatory inquiry requiring a response by a specific deadline. Since it is a regulatory announcement that does not fit into specific categories like earnings or dividends, it falls under the RNS (Regulatory Filings) category.
2020-05-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.